Exercise-carroussel in inpatient dementia care

Not Applicable

• Conditions: F00; F01; F02; F03; G30; Dementia in Alzheimer disease; Vascular dementia; Dementia in other diseases classified elsewhere; Unspecified dementia; Alzheimer disease

• Registration Number: DRKS00006740
• Lead Sponsor: VR-Klinik KölnAbt. für Gerontopsychiatrie und -psychotherapie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-10-28
• Study Completion: 2015-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 87

Inclusion Criteria

diagnosis of dementia following ICD-10-Criteria
- minimum length of stay: 1 week in order to submit familiarization to the new setting
- exclusion of delirium (Confusion Assessment Method)
- ability to perform the timed-up and go-test [19] without human assistance
- written consent of the legal guardians

Exclusion Criteria

- acute cardial instability, that allows no physical exercise
- behavior that allows no group exercise

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
behavioral and psychological symptoms (measured via standardised interview with the primary nurse of the patient): <br>- Neuropsychiatric Inventory (pre and post 2-weeks-intervention)<br>- Cohen-Mansfield-Agitation Inventory (pre and post 2-weeks-intervention)<br>- ADCS-CGIC (Alzheimer-Cohort-Study clinical global impression of change) (post 2-weeks intervention)

Secondary Outcome Measures

Name	Time	Method
- caregiver-burden, measured via NPI-Caregiver-Version (structured interview); carried out pre and post two-week intervention<br>- PRN-Medication while intervention-phase<br>- functional performance assessed via Timed Up and Go-Test + 10m Gaitspeed; pre and post two-week-intervention<br>- motion behavior measured via body-fixed sensors (Stepwatch + uSense-Sensor) on four days pre and post two-week intervention<br>- day-structure (cortisol-profiles) measured via saliva probes on two consecutive days pre and post two-week intervention<br>- brain derieved neurotrophic factor (BDNF): measured via one blood probe pre and post two-week intervention<br>- falls and use of physical constraints while the two-week-intervention (as registered in the clinical information system)